Biologics and Biosimilars Market Key Regions, Company Profile, Opportunity and Challenge 2027 - Roche, Amgen, AbbVie, Sanofi-Aventis
The data studied for the preparation of the report takes into account the current major players and the major players that will be listed. Industry top players are: Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories
The Global Biologics and Biosimilars Market Size is Projected to Reach at a CAGR of 24.22% during 2021-2027.
Click Here To Get A Free Sample Copy:
Covid-19 Impact and Recovery Analysis:
The number one goal of this Biologics and Biosimilars Market document is to provide Quantitative records withinside the form of charts and graphs. The information regarding market fundamentals is provided surely for the sake of readers. All the readers on the side of stakeholders will understand the market situations and business enterprise environment because it needs to be through this properly-planned Market analysis. It turns smooth to collect the effect of COVID-19 on the market boom through this Biologics and Biosimilars market document.
Biologics and Biosimilars market Segmentation By Type:
Biologics and Biosimilars market Segmentation By Application:
Key Market Trends
The Oncology Segment Holds the Major Share in the Global Biosimilars Market
The oncology segment is expected to hold the major share in the biosimilars market, and the high incidence of cancers worldwide is the major factor driving the growth of the studied market over the forecast period. According to Globocan 2020, the incidence of new cancer cases was estimated to be 19,292,789 in 2020, with nearly 9,958,133 deaths due to cancers. Additionally, the new cancer incidence is estimated to reach 30.2 million by 2040, as per the International Agency for Research on Cancer (IARC).
In the COVID-19 era, nearly 88% of the cancer care centers faced challenges in delivering usual cancer care for many reasons, including precautionary measures, lack of personal protective equipment, and staff shortage as per the research article published in the JCO Global Oncology 2020. Additionally, this impact was more pronounced in low-income countries. Therefore, COVID-19 is expected to hinder the number of cancer therapies offered to cancer patients, which indirectly is expected to impact the studied segment.
Recent Developments in Biologics
In August 2021, Moderna, Inc. announced that it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older.
In August 2021, Pfizer Inc.and BioNTech SE announced the initiation of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for the approval of a booster (third) dose of COMIRNATY (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years of age and older.
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
For The Full Report Click here:
Significant Features and Key Highlights of the Reports:
– Detailed overview of Biologics and Biosimilars Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc.
– Historical, current and projected market size in terms of volume and value.
– Recent industry trends and developments
– Competitive landscape of Biologics and Biosimilars Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.
The report gives answers to the following:
What strategies are followed by key players to fight this Covid-19 situation?
What are the essential matters drivers, opportunities, challenges, and dangers of the market will face surviving?
Which are the leading market players in the Biologics and Biosimilars industry?
What is the predicted compound annual growth rate (CAGR) of the global marketplace during the forecast period (2021-2027)?
What could be the anticipated value of the Biologics and Biosimilars marketplace in the during the forecast period?
Impact of COVID-19:
The research includes historic data from 2016 to 2021 and forecasts until 2027 which makes the Biologics and Biosimilars market report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.
The Global Biologics and Biosimilars Market report may be modified to meet your specific business needs. Because we understand what our clients want, we provide up to 20% customization for any of our Market Intelligence Data reports at no additional cost to all of our Users.
Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA
Phone: +1 (704) 266-3234
Mail to: firstname.lastname@example.org
Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics and Biosimilars Market Key Regions, Company Profile, Opportunity and Challenge 2027 - Roche, Amgen, AbbVie, Sanofi-Aventis here
News-ID: 2393498 • Views: 739
More Releases from Market Insights Reports
Gate Shut-Off Valve Market 2021 Exclusive Manufacturers – Schneider Electric, …
Latest released, the research study on Global Gate Shut-Off Valve Market Report Forecast 2021 - 2027, offers a detailed overview of the factors influencing the global business scope. Gate Shut-Off Valve Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Gate Shut-Off Valve.
Industrial Humidity Sensors Market Research With Size, Growth, Manufacturers, Se …
Latest released, the research study on Global Industrial Humidity Sensors Market Report Forecast 2021 - 2028, offers a detailed overview of the factors influencing the global business scope. Industrial Humidity Sensors Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Industrial Humidity Sensors.
Point Of Sale System Market 2021 Technology Development, Key Manufacturers, Fore …
Latest released, the research study on Global Point Of Sale System Market Report Forecast 2021 - 2027, offers a detailed overview of the factors influencing the global business scope. Point Of Sale System Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Point
Perimeter Security Market – Industry Analysis, Technological Innovations, Tren …
Latest released, the research study on Global Perimeter Security Market Report Forecast 2021 - 2028, offers a detailed overview of the factors influencing the global business scope. Perimeter Security Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Perimeter Security. The study covers
More Releases for Biologics
Global Biologics Size and Segments
The Business Research Company’s global Biologics market report, covers the year-on-year growth of the global Biologics market historic and forecast growth. It also includes chapters on the Biologics market trends, Biologics geographical analysis, Biologics driver and restraints, and Biologics leading competitors’ revenues, profiles and market shares. Order The Global Biologics Market Report At: https://www.thebusinessresearchcompany.com/report/biologics-global-market-opportunities-and-strategies-to-2021 Global Biologics Market Segments The Biologics industry can be further categorized into -monoclonal antibodies (mAbs) market, therapeutic proteins market,
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Oral Biologics Market Opportunity Analysis, 2018-2026
Oral biologics represent a novel category of drugs, which is gaining traction in the last few decades. Biologic therapeutics has proven to be a highly effective treatment for various chronic ailments, such as diabetes, plaque psoriasis, arthritis, plaque psoriasis, Crohn’s disease, and ulcerative colitis. The major concern regarding oral biologics is to protect the protein from degradation and digestion in the gastrointestinal tract. The first products were mostly insulin-related, novel
Spine Biologics Market Industry Analysis
Spine Biologics Market was worth USD 2.07 billion in 2016 and estimated to be growing at a CAGR of 4.4%, to reach USD 2.56 billion by 2021. Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation through inflammatory stage, repair stage, and remodeling stage. Therefore, surge in the number of
Biologics Market | Key Opportunities And Forecast 2024
The Global Market For Biologics features a fragmented competitive landscape with stakeholders being some of the world’s most influential pharmaceutical companies and several domestic companies, which are vying for a share in the highly profitable market, observes Transparency Market Research (TMR) in a recent report. “A popular trend in the market is strategic mergers and acquisitions, with big companies wanting to expand their services and manufacturing units globally and enhancing